Caliper Life Sciences Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 140.7 | 107.9 | 87.0 |
| Cost of Goods Sold | 74.6 | 60.6 | 48.3 |
| Gross Profit | 66.1 | 47.3 | 38.8 |
| Gross Profit Margin | 47.0% | 43.8% | 44.5% |
| SG&A Expense | 75.9 | 64.7 | 46.2 |
| Depreciation & Amortization | 14.0 | 12.5 | 7.1 |
| Operating Income | (23.8) | (30.0) | (14.6) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 1.2 | 1.4 | 0.2 |
| Nonoperating Expenses | 1.2 | 0.4 | 0.0 |
| Income Before Taxes | (23.8) | (29.0) | (14.3) |
| Income Taxes | 0.3 | (0.1) | 0.1 |
| Net Income After Taxes | (24.1) | (28.9) | (14.5) |
| Continuing Operations | (24.1) | (28.9) | (14.5) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (24.1) | (28.9) | (14.5) |
| Total Net Income | (24.1) | (28.9) | (14.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.51) | (0.75) | (0.46) |
| Dividends per Share | -- | -- | -- |






